Welcome to visit Weimao!
Current location:front page >> healthy

Seili Medical increases capital for Wuhan Huajiyuan Bio to support the development of hypertensive vaccines

2025-09-19 05:21:58 healthy

Seili Medical increases capital for Wuhan Huajiyuan Bio to support the development of hypertensive vaccines

Recently, Selli Medical announced a strategic capital increase to Wuhan Huajiyuan Bio to support its research and development project for hypertension vaccines. This cooperation has attracted widespread attention from the industry and has become one of the hotly discussed areas of medical and health care that have been hotly discussed across the Internet in the past 10 days. This article will combine structured data to analyze the significance of this cooperation and the current progress in the development of hypertensive vaccines.

1. Cooperation background and core data

Seili Medical increases capital for Wuhan Huajiyuan Bio to support the development of hypertensive vaccines

The amount of funds and shareholding ratio of Selli Medical this time are shown in the following table:

InvestorInvested in the companyIncreased funds (billion yuan)Shareholding ratio
Selli MedicalWuhan Huajiyuan Biology1.522.5%

Wuhan Huajiyuan Biological was founded in 2018 and focuses on the research and development of innovative therapies for cardiovascular diseases. Its hypertension vaccine project has entered the preclinical research stage. The following table shows the key time nodes of the project:

R&D stageEstimated completion timeMain objectives
Preclinical research2024Q2Complete animal experiments
Phase I clinical2025Q1Security Verification
Phase II clinical2026Q3Validity Assessment

2. Analysis of the market potential of hypertensive vaccines

According to data from the National Center for Cardiovascular Disease, the number of hypertensive patients in my country continues to rise, and the market has an urgent need for innovative therapies:

yearsNumber of patients (billions)Treatment rateControl rate
20202.4545.8%16.8%
20232.748.3%18.2%

Industry experts pointed out that compared with traditional antihypertensive drugs, hypertensive vaccines have significant advantages:

Contrast dimensionsTraditional medicineVaccine Therapy
Frequency of medicationTake it dailyHalf a year/time
ComplianceAbout 60%Estimated 85%+
side effectMore commonProbably lower

3. Capital market reaction and industry impact

After the news was announced, the stock prices of relevant companies were as follows:

Company Name3-day increaseChanges in trading volume
Selli Medical+12.6%Increased 280%
Biomedical sector+3.2%Grow 45%

It is worth noting that this is the first hypertensive vaccine project in China to receive strategic investment from listed companies. Analysts believe that this move will accelerate the development process of domestic cardiovascular innovative drugs. The following table lists the recent progress of similar R&D projects:

enterpriseR&D stageTechnical route
Huajiyuan BiologyPreclinicalDNA vaccine
International Pharmaceutical Company APhase II clinicalAntibody vaccine
Research Institution BBasic researchRNA vaccine

4. Expert views and future prospects

Many industry experts expressed optimism about this cooperation. Professor Wang of the Chinese Academy of Medical Sciences pointed out: "The research and development of hypertensive vaccines requires long-term investment, and strategic cooperation among enterprises can effectively share risks." The CEO of Wuhan Huajiyuan revealed that the new funds will be mainly used for:

useFund share
Preclinical research40%
Talent introduction30%
Equipment upgrade20%
other10%

Seli Medical said that it will consider additional investment in the future based on the progress of R&D and plans to establish a joint laboratory. The industry predicts that if the R&D goes smoothly, the vaccine is expected to be approved for market launch around 2028, and the potential market size can reach 10 billion yuan.

This cooperation not only brings new hope for patients with hypertension, but also marks an important step in the field of cardiovascular innovative drugs. As population aging intensifies, the market value of preventive medical products will become increasingly prominent.

Next article
  • Your stomach hurts no matter what you eat? Analysis of hot health topics in the past 10 daysIn the past 10 days, discussions about "gastrointestinal discomfort" have soared on social media and health forums, with many netizens reporting that "everything they eat makes their stomach hurt." From dietary taboos to potential illnesses, the phenomenon has sparked widespread concern. The following are hot topics and struct
    2026-01-26 healthy
  • What kind of tea can you drink to get rid of kidney stones? Analysis of hot topics on the Internet in 10 daysRecently, dietary treatment methods for kidney stones have become a hot topic in the health field, especially the effect of tea in removing stones, which has triggered widespread discussion. This article will combine the hot content on the Internet in the past 10 days to sort out the scientific basis and pract
    2026-01-23 healthy
  • What causes male spermatorrheaNocturnal emissions are the involuntary discharge of semen during sleep, which usually occurs in adolescent and adult men. Although this is a normal physiological phenomenon, frequent nocturnal emissions may be related to a variety of factors. This article will combine the hot topics and hot content on the Internet in the past 10 days, analyze the causes of spermatorrhea from the aspects
    2026-01-21 healthy
  • What can't you eat if you have a sore throat? List of 10 taboo foods and scientific adviceRecently, "pharyngitis" and "swollen and sore throat" have become hot topics on social platforms. Especially with the change of seasons and the high incidence of influenza, related searches have surged. This article combines the hot health content on the Internet in the past 10 days to sort out a list of dietary taboos during th
    2026-01-18 healthy
Recommended articles
Friendly links
Dividing line